词条 | Hexoprenaline |
释义 |
| Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 444541801 | IUPAC_name = (±)-4,4'- | image = Hexoprenaline.svg | width = 225px | chirality = Racemic mixture |pronounce={{IPAc-en|ˌ|h|ɛ|k|s|oʊ|ˈ|p|r|ɛ|n|ə|l|iː|n}} {{respell|HEKS|oh|PREN|ə|leen}} | tradename = | Drugs.com = {{drugs.com|international|hexoprenaline}} | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = ℞-only | routes_of_administration = Oral (tablets), IV | bioavailability = 5–11% (Tmax = 2 hours) | protein_bound = | metabolism = COMT (slow O-methylation) | elimination_half-life = ~50 minutes (if taken orally) | excretion = Feces (~90%)[1] | CAS_number_Ref = {{cascite|correct|??}} | CAS_number = 3215-70-1 | ATC_prefix = R03 | ATC_suffix = AC06 | ATC_supplemental = {{ATC|R03|CC05}} | PubChem = 3609 | DrugBank_Ref = {{drugbankcite|changed|drugbank}} | DrugBank = DB08957 | KEGG_Ref = {{keggcite|changed|kegg}} | KEGG = D08039 | UNII_Ref = {{fdacite|correct|FDA}} | UNII = G9L6B3W684 | ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} | ChemSpiderID = 3483 | chemical_formula = | C = 22 | H = 32 | N = 2 | O = 6 | molecular_weight = 420.499 g/mol | smiles = C1=CC(=C(C=C1C(CNCCCCCCNCC(C2=CC(=C(C=C2)O)O)O)O)O)O | synonyms = 4-[2-[6-[[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino]hexylamino]-1-hydroxyethyl]benzene-1,2-diol | StdInChI_Ref = {{stdinchicite|changed|chemspider}} | StdInChI = 1S/C22H32N2O6/c25-17-7-5-15(11-19(17)27)21(29)13-23-9-3-1-2-4-10-24-14-22(30)16-6-8-18(26)20(28)12-16/h5-8,11-12,21-30H,1-4,9-10,13-14H2 | StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} | StdInChIKey = OXLZNBCNGJWPRV-UHFFFAOYSA-N }} Hexoprenaline is a selective β2 adrenergic receptor agonist used in the treatment of asthma.[2] Hexoprenaline is also used in some countries (such as Russia and Switzerland) as a tocolytic agent (i.e., labor suppressant), with the most common trade name being Gynipral.[3] [4] It is not approved by U.S. FDA. ContraindicationsWhen used as a tocolytic, hexoprenaline is contraindicated in:
It should be used with caution in people with gestational diabetes. Drug-drug interactionsWhen concomitantly administered:
Hexoprenaline is contraindicated for use with monoamine oxidase inhibitors (MAOIs), tricyclic antidepressant (TCAs), ergot alkaloids, and dihydrotachysterol.[3] References1. ^1 {{cite web|title=Gynipral (hexoprenaline) Full Prescribing Information|url=http://grls.rosminzdrav.ru/Grls_View_v2.aspx?idReg=143837&t=|website=Russian State Register of Medicinal Products|publisher=Nycomed Austria GmbH. St. Peter-Straße 25, A-4020, Linz, Austria|accessdate=19 March 2016|language=Russian}} {{Other gynecologicals}}{{Drugs for obstructive airway diseases}}{{Adrenergics}}{{respiratory-system-drug-stub}}2. ^{{cite journal|last1=Pinder|first1=RM|last2=Brogden|first2=RN|last3=Speight|first3=™|last4=Avery|first4=GS|title=Hexoprenaline|journal=Drugs|date=July 1977|volume=14|issue=1|pages=1–28|doi=10.2165/00003495-197714010-00001|pmid=195789}} 3. ^1 2 {{cite web|title=Gynipral (hexoprenaline) Tablets 0.5 mg, Solution for Intravenous Infusion 5 μg/mL (0.0005%)|url=http://www.rlsnet.ru/tn_index_id_1005.htm|website="RLS" (РЛС): Russian Register of Medical Products|language=Russian|accessdate=19 March 2016}} 4. ^{{cite web|title=GYNIPRAL Inj Lös 10 mcg/2ml|url=https://compendium.ch/prod/gynipral-inj-los-10-mcg-2ml/de|website="Compendium": Swiss Register of Medical Products|language=German|accessdate=3 April 2017}} 4 : Antiasthmatic drugs|Beta-adrenergic agonists|Catecholamines|Tocolytics |
随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。